| ATCC 51271| Catonella morbi| Catonella morbi Moore and Moore 1994| CCUG 33640| VPI D154F-12
Gut microbiota: Catonella morbi is part of the complex ecosystem of the gut microbiota, where it interacts with other microorganisms and influences overall gut health. The gut microbiota plays important roles in digestion, nutrient metabolism, immune function, and protection against pathogens.
Fermentation and SCFA production: Like other members of the Lachnospiraceae family, Catonella morbi is capable of fermenting dietary fibers and complex carbohydrates in the colon. During fermentation, it produces short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate. SCFAs have various health benefits, including serving as an energy source for colonocytes, regulating immune responses, and maintaining gut barrier function.
Metabolic health: The production of SCFAs by Catonella morbi and other gut microbes influences host metabolism, energy balance, and glucose homeostasis. SCFAs, particularly butyrate, have been associated with improvements in metabolic health, including enhanced insulin sensitivity, reduced inflammation, and protection against obesity and metabolic syndrome.
Immune modulation: Catonella morbi and its metabolic products may interact with the host immune system and contribute to immune modulation in the gut mucosa. SCFAs produced during fermentation have immunomodulatory effects and can influence the development and function of immune cells such as regulatory T cells (Tregs) and dendritic cells, which play important roles in maintaining immune tolerance and inflammation control.
Disease associations: While specific information about the disease associations of Catonella morbi is limited, alterations in the abundance or composition of Lachnospiraceae bacteria, including Catonella morbi, have been observed in various gastrointestinal disorders such as inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), and colorectal cancer. Changes in the gut microbiota composition may contribute to disease pathogenesis or serve as markers of disease activity.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 0.66 | 6 | 210 | 0 | 143 | 41 | 20 | 52.3 | 6 | 210 | 5.9 %ile | 88.2 %ile | ||
biomesight | 64.92 | 0 | 70 | 10 | 160 | 0 | 299 | 97 | 60 | 103 | 0 | 180 | 3.7 %ile | 91 %ile |
thryve | 95.13 | 32 | 753 | 105 | 731 | 0 | 3406 | 505.9 | 314 | 1479.5 | 16 | 836 | 11.2 %ile | 90.5 %ile |
ubiome | 0.13 | 0 | 644 | 644 | 644 | 644 | 644 | 0 %ile | 99 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 72.381 % | 0.01 % | 0.01 % | 2073.0 | 2864 |
BiomeSightRdp | 18.75 % | 0.004 % | 0.003 % | 6.0 | 32 |
CosmosId | 3.125 % | 0.002 % | % | 1.0 | 32 |
custom | 5.085 % | 0.015 % | 0.01 % | 3.0 | 59 |
Medivere | 57.143 % | 0.001 % | 0 % | 4.0 | 7 |
Thryve | 95.806 % | 0.048 % | 0.133 % | 1325.0 | 1383 |
uBiome | 0.126 % | 0.064 % | % | 1.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.